Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ingram

Showing results (431-440 of 507) with videos related to

Pageof 51
Sort By:
Lancet (London, England)|May 25, 2024
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trialsAlexa B Kimball, Gregor B E Jemec, Christopher J Sayed, et al.
The British Journal of Dermatology|August 19, 2025
The HIdradenitis suppurativa DrainagE (HIDE) Scale: development and content validation of patient reported outcome measureLinnea Thorlacius, Bente Villumsen, Barry M McGrath, et al.
Pharmaceutical Biotechnology|January 1, 1996
A compendium and hydropathy/flexibility analysis of common reactive sites in proteins: reactivity at Asn, Asp, Gln, and Met motifs in neutral pH solutionG Amphlett, J Cacia, W Callahan, et al.
Internal Medicine Journal|November 6, 2023
Nocardia species distribution and antimicrobial susceptibility within AustraliaAine O'Brien, Julie Hart, Ammie Higgins, et al.
The British Journal of Dermatology|November 17, 2023
Global consensus process to establish a core dataset for hidradenitis suppurativa registriesHannah E Wainman, Nisha S Chandran, John W Frew, et al.
BMC Cancer|November 18, 2015
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomasCaitlin D May, Jeannine Garnett, XiaoYan Ma, et al.
The British Journal of Dermatology|June 22, 2017
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severityC C Zouboulis, T Tzellos, A Kyrgidis, et al.
Cancer Cell|June 5, 2018
The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial SarcomaMatthew J McBride, John L Pulice, Hannah C Beird, et al.
Archives of Dermatological Research|January 20, 2024
Clinical relevance and uptake of core outcome sets in dermatologyAreeba Ahmed, Eric Koza, Victoria Shi, et al.
Journal of the American Academy of Dermatology|March 18, 2019
Navigating the landscape of core outcome set development in dermatologyCecilia A C Prinsen, Phyllis I Spuls, Jan Kottner, et al.
Pageof 51

Showing results (431-440 of 507) with videos related to

Sort By:
Pageof 51
Lancet (London, England)|May 25, 2024
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trialsAlexa B Kimball, Gregor B E Jemec, Christopher J Sayed, et al.
The British Journal of Dermatology|August 19, 2025
The HIdradenitis suppurativa DrainagE (HIDE) Scale: development and content validation of patient reported outcome measureLinnea Thorlacius, Bente Villumsen, Barry M McGrath, et al.
Pharmaceutical Biotechnology|January 1, 1996
A compendium and hydropathy/flexibility analysis of common reactive sites in proteins: reactivity at Asn, Asp, Gln, and Met motifs in neutral pH solutionG Amphlett, J Cacia, W Callahan, et al.
Internal Medicine Journal|November 6, 2023
Nocardia species distribution and antimicrobial susceptibility within AustraliaAine O'Brien, Julie Hart, Ammie Higgins, et al.
The British Journal of Dermatology|November 17, 2023
Global consensus process to establish a core dataset for hidradenitis suppurativa registriesHannah E Wainman, Nisha S Chandran, John W Frew, et al.
BMC Cancer|November 18, 2015
AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomasCaitlin D May, Jeannine Garnett, XiaoYan Ma, et al.
The British Journal of Dermatology|June 22, 2017
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severityC C Zouboulis, T Tzellos, A Kyrgidis, et al.
Cancer Cell|June 5, 2018
The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial SarcomaMatthew J McBride, John L Pulice, Hannah C Beird, et al.
Archives of Dermatological Research|January 20, 2024
Clinical relevance and uptake of core outcome sets in dermatologyAreeba Ahmed, Eric Koza, Victoria Shi, et al.
Journal of the American Academy of Dermatology|March 18, 2019
Navigating the landscape of core outcome set development in dermatologyCecilia A C Prinsen, Phyllis I Spuls, Jan Kottner, et al.
Pageof 51